Element Peptides / Journal
Read across materials, methods and documentation.
46 articles
Tesamorelin is a synthetic GHRH analog investigated for selective visceral adipose reduction through physiologic GH axis activation. Clinical trials demonstrate preferential intra-abdomin...
Read articleThis research-oriented article analyzes how fatty-acid conjugation influences semaglutide pharmacokinetics in experimental metabolic systems. It discusses albumin-binding behavior, mechan...
Read articleThis research-focused article explores how tirzepatide regulates cardiometabolic biomarkers through dual incretin receptor activation. It reviews findings from controlled clinical trials ...
Read articleThis research-focused analysis examines how tirzepatide alters cardiometabolic biomarkers through combined activation of the incretin receptors. Evidence from controlled clinical investig...
Read articleRetatrutide’s triple-receptor activation establishes a structured scientific model for investigating neuroendocrine appetite dysregulation in binge eating disorder. By integrating GLP-1 d...
Read articleCagrilintide, an extended-acting amylin analogue, is attracting scientific interest as a potential investigational strategy for lowering prediabetes risk. Through appetite modulation, red...
Read articleSemaglutide is a GLP-1 receptor agonist extensively studied for its metabolic effects, including potential relevance in nonalcoholic fatty liver disease research. It influences insulin se...
Read articleThis research-oriented article examines AOD-9604 and its potential role in lipogenesis pathway investigation through modulation of C-terminal growth hormone activity. It integrates mechan...
Read articleThis research-oriented review evaluates Orforglipron as a non-peptide small-molecule GLP-1 receptor agonist in metabolic research. It outlines key distinctions from peptide-derived GLP-1 ...
Read articleThis article examines the use of Melanotan II to investigate melanocortin receptor signaling in appetite-regulation research models. It examines mechanistic pathways, receptor-level inter...
Read articleTesamorelin-associated changes in body composition are often attributed to IGF-1 elevation; however, growing evidence indicates the involvement of additional regulatory pathways. In addit...
Read articleTirzepatide is a dual GIP and GLP-1 receptor agonist with growing importance in MASLD and MASH research. Experimental and clinical findings demonstrate reductions in hepatic fat, enhanced...
Read article